RxDoctor Payments Data

Heather Ball, PA

Physician Assistant · Roanoke, VANPI 1063661049

Payments from drug & device makers

$7,372in general payments, 2019–2025

Across 433 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$843
  • Lilly USA, LLC$805
  • Pfizer$527
  • Otsuka America Pharmaceutical, Inc.$496
  • Amgen$402
  • plus $3K from 31 others

What the payments were for

  • Food & beverage$7,372100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,372 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$105,228
Medicare patients
280
Services billed
2,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$69,986
JardianceEmpagliflozin87$69,769
OzempicSemaglutide28$44,181
MounjaroTirzepatide43$44,002
FarxigaDapagliflozin Propanediol27$28,167
JanuviaSitagliptin Phosphate24$21,917
LinzessLinaclotide19$20,617
RybelsusSemaglutide11$19,183
XareltoRivaroxaban16$14,475
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$11,081
MovantikNaloxegol Oxalate17$6,781
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen170$4,192
SymbicortBudesonide/Formoterol Fumarate14$3,930
PremarinEstrogens, Conjugated17$3,882
Esomeprazole Magnesium46$3,403

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$527$73,86876 claims
Boehringer IngelheimJardiance$71$69,76987 claims
Novo NordiskOzempic, Rybelsus$1,517$63,36539 claims
Lilly USA, LLCMounjaro$805$44,00243 claims
AstraZenecaFarxiga, Symbicort$346$32,09741 claims
AbbVieLinzess, Synthroid$843$22,13157 claims
MerckJanuvia$200$21,91724 claims
Johnson & JohnsonXarelto$179$14,47516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →